All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| LSBPW / LakeShore Biopharma Co., Ltd - Equity Warrant
|
|
|
|
|
|
|
|
| RLAY / Relay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| CLDI.WS / First Light Acquisition Group, Inc. - Equity Warrant
|
|
|
|
|
|
|
|
| FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SAVE / Spirit Airlines, Inc. Call
|
|
|
|
|
|
|
|
| CCVI.WS / Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exe
|
|
|
|
|
|
|
|
| CCV.WS / Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exer
|
|
|
|
|
|
|
|
| CERE / Cerevel Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
| BRIDGETOWN HOLDINGS LTD
/ *W EXP 09/30/202 (G1355U121) |
|
|
|
|
|
|
|
| AAC.WS / Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ord
|
|
|
|
|
|
|
|
| ROSS.WS / Ross Acquisition Corp II - Equity Warrant
|
|
|
|
|
|
|
|
| US43734R1115 / Home Plate Acquisition Corp.
|
|
|
|
|
|
|
|
| MORF / Morphic Holding, Inc.
|
|
|
|
|
|
|
|
| KYG638361116 / Swiftmerge Acquisition Corp.
|
|
|
|
|
|
|
|
| GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| CNDA.WS / Concord Acquisition Corp II - Equity Warrant
|
|
|
|
|
|
|
|
| TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
| / Compass Digital Acquisition Corp
|
|
|
|
|
|
|
|
| ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
| PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
| CVII.WS / Churchill Capital Corp VII - Equity Warrant
|
|
|
|
|
|
|
|
| SWTX / SpringWorks Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LBRDK / Liberty Broadband Corporation
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SLDB / Solid Biosciences Inc.
|
|
|
|
|
|
|
|
| CLDI / Calidi Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
| US56608A1135 / Marblegate Acquisition Corp.
|
|
|
|
|
|
|
|
